Hledání článků
Filtry
KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int 2012;2(Suppl 4):279–336.
Turner JM, Bauer C, Abramowitz K, et al. Treatment of chronic kidney disease. Kidney Int 2012;81:351–362.
Holfthoff JH, Wang Z, Seely KA, et al. Resveratrol improves renal microcirculation, protects the tubular epitelium, and prolongs surfoval in mouse model of sepsis‑induced acute kidney injury. Kidney Int 2012,81:370–378
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2012; e‑pub ahead of print.
Floege J, Raggi P, Block GA, et al. Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in hemodialysis patients. Nephrol Dial Transplant 2010;25:1916–1923.
Raggi P, Chertow GM, Urena‑Torres P, et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low‑dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 2010;26:1327–1339.
Urena‑Torres P, Floege J, Hawley CM, et al: Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study. Nephrol Dial Transplant 2012, doi: 10.1093/ndt/gfs356
Molnar MZ, Mehrotra R, Duong U, Bunnapradist S, Lukowsky L, Krishnan M, Kovesdy CP, Kalantar‑Zadeh K. Dialysis modality and outcomes in kidney transplant recipients. Clin J Am Soc Nephrol 2012;7:332–341.
Melcher ML, Leeser DB, Gritsch HA, Milner J, Kapur S, Busque S, Roberts JP, Katznelson S, Bry W, Yang H, Lu A, Mulgaonkar S, Danovitch GM, Hil G, Veale JL. Chain transplantation: initial experience of a large multicenter program. Am J Transplant. 2012;12:2429–2436.
Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012;367:20–29.
Hemmelgarn BR, James MT, Manns BJ, et al. Rates of treated and untreated kidney failure in older vs. younger adults. JAMA 2012;307:2507–2515.
Rahman M, Ford CE, Cutler JA, Davis BR, Piller LB, Whelton PK, Wright JT Jr, Barzilay JI, Brown CD, Colon PJ Sr, Fine LJ, Grimm RH Jr, Gupta AK, Baimbridge C, Haywood LJ, Henriquez MA, Ilamaythi E, Oparil S, Preston R; for the ALLHAT Collaborative Research Group. Long‑term renal and cardiovascular outcomes in Antihypertensive and Lipid‑Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR. Clin J Am Soc Nephrol 2012;7:989–1002.
Fassett RG, Robertson IK, Ball B, el al. Effect of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial. Nephrol Dial Transpl 2012;27:182–189.
Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within ANCA‑associated vasculitis. N Engl J Med 2012;367:214–223.